{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-261722","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2025-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.864928+00:00","generated_at":"2026-05-17T00:52:58.831645+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Corbus Pharmaceuticals prices $75M public offering of common stock and warrants","bullets":["Offering of 4,744,231 shares at $13.00/share and 1,025,000 pre-funded warrants at $12.9999 each for ~$75M gross proceeds.","Net proceeds to Corbus expected ~$70.5M; underwriters have 30-day option for additional 865,384 shares.","Proceeds to fund clinical pipeline development and general corporate purposes.","Pre-funded warrants exercisable immediately at $0.0001/share, capped at 9.99% beneficial ownership.","Jefferies leads underwriting; RBC, LifeSci Capital, Mizuho as lead managers."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-261722","json":"https://secwatch.observer/filing/0001193125-25-261722.json","markdown":"https://secwatch.observer/filing/0001193125-25-261722.md","text":"https://secwatch.observer/filing/0001193125-25-261722.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525261722/0001193125-25-261722-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525261722/crbp-20251030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:52:58.831645+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}